04 April 2025
04 April 2025
During a webinar hosted by NAMSA, experts reflected on what US health agency job cuts could mean for device approvals and innovation.
South Korean startups showcased innovative technologies addressing dementia care and prevention for aging national populations.
Both companies’ boards of directors gave unanimous approval for the transaction.
The partnership focuses on standardising and managing the lifecycle of Tower Health's imaging equipment.
Pounce XL complements Surmodics’ thrombectomy platform, now offering clot excision for arteries between 2mm and 10mm in diameter.
The system comprises an implantable pulse generator that generates electrical stimulation.
Research indicates that leaky progesterone pessaries used in threatened miscarriage cases cost the NHS £236m in avoidable costs yearly.
The financing round includes a debt investment from alternative asset manager Trinity Capital.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
